Psoriasis Drugs Among Leaders in Drug Side Effect Reporting

Is it time to look at psoriasis treatment in a new light?

HORSHAM, PA, March 31, 2017 /PRNewswire/ – According to a recent USA Today Network Exclusive analysis*, the number of drug side effect reports filed with the U.S. Food and Drug Administration (FDA) has increased five-fold from 2004 to 2015. This equated to more than 1.2 million reports in 2015.1

This analysis showed that the drugs used to treat psoriasis and other autoimmune disorders such as rheumatoid arthritis and Crohn’s disease are among those with the greatest number of reports.1 These drugs work by suppressing the immune system, which can increase the risk of serious or even potentially deadly infections such as tuberculosis. They have also been associated with blood diseases, cancer and lymphomas.2

The article goes on to mention Humira (approved to treat 10 different conditions including psoriasis) specifically as an autoimmune drug that has been linked to over 200,000 side effect reports since 2013, including 4,200 deaths.1

The other drugs cited as being top contributors in terms of number of side effect reports are those used to treat multiple sclerosis, a type of cancer, and those used to treat diabetes.1

The authors of this exclusive, Matthew Wynn* and John Fauber*, acknowledge that although the dramatic increase in reports may be indicative of a growing number of patients being harmed, it could also be a result of more vigilant reporting, which is a goal the FDA is striving to achieve. They go on to say that it very well may be that the increase is a result of a combination of the two, according to experts.1

In addition to the autoimmune drugs that are used to treat psoriasis, topical therapies (such as creams and ointments), other drugs taken orally and light therapy are treatment options that can be considered.3 Light therapy, as stated in the American Academy of Dermatology guidelines of care for the management of psoriasis:3

“…is effective and economical without many of the potential toxicities [side effects] of traditional and biologic [autoimmune drug] therapies.

At STRATA Skin Sciences, Inc. (SSKN) (“STRATA”), we are committed to helping patients suffering from serious dermatologic conditions, such as psoriasis, through our innovative medical technologies including our XTRAC targeted-light therapy.

What makes XTRAC Therapy an attractive option for patients with psoriasis, especially when considering this new information on drug side effect reporting, is that it works very effectively but is associated with virtually no side effects. Over 100,000 patients have been safely treated with XTRAC Therapy.4 Some patients may experience a reaction similar to sunburn or some blistering at the area treated, and in some cases an increase in skin pigmentation may occur.

Next Page

Be the first to comment

Leave a Reply

Your email address will not be published.